Atlas Trials

A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL

Clinical trial NCT05421611 · COMPLETED

Trial details

NCT number
NCT05421611
Sponsor
Serum Institute of India Pvt. Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Yellow Fever
Start date
2023-05-11
Primary completion
2024-05-10
Enrollment
1824

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.